Zacks Research lowered shares of Sonic Healthcare (OTCMKTS:SKHHY – Free Report) from a hold rating to a strong sell rating in a report published on Wednesday morning,Zacks.com reports.
Sonic Healthcare Stock Up 3.6%
OTCMKTS SKHHY opened at $14.86 on Wednesday. Sonic Healthcare has a 1-year low of $12.94 and a 1-year high of $19.25. The stock’s 50 day moving average is $14.14 and its two-hundred day moving average is $14.73. The company has a quick ratio of 0.90, a current ratio of 1.01 and a debt-to-equity ratio of 0.59.
About Sonic Healthcare
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Further Reading
- Five stocks we like better than Sonic Healthcare
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
